BL-M02D1, a novel Trop2-targeting ADC, demonstrates robust anti-tumor efficacy in preclinical evaluation

被引：1
|
作者：
Zhang, Yong
Wan, Weili
Zhuo, Shi
Chen, Lan
Li, Gangrui
Zhao, Shuwen
Khalili, Jahan Salar
Xiao, Sa
Yan, Yongqi
Shen, Xuejiao
Zhu, Yi
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2644
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2644
引用
收藏
页数：2
相关论文
共 21 条
  • [1] BL-M11D1, a novel CD33-targeting ADC, demonstrates robust anti-tumor efficacy in preclinical evaluation
    Wan, Weili
    Zhao, Shuwen
    Zhuo, Shi
    Zhang, Yong
    Chen, Lan
    Li, Ruigang
    Khalili, Jahan Salar
    Sa, Xiao
    Yan, Yongqi
    Shen, Xuejiao
    Zhu, Yi
    CANCER RESEARCH, 2024, 84 (06)
  • [2] BL-B01D1, a novel EGFR x HER3-targeting ADC, demonstrates robust anti-tumor efficacy in preclinical evaluation
    Wan, Weili
    Zhao, Shuwen
    Zhuo, Shi
    Zhang, Yong
    Chen, Lan
    Li, Gangrui
    Renshaw, Blair
    Khalili, Jahan Salar
    Xiao, Sa
    Zhu, Yi
    CANCER RESEARCH, 2023, 83 (07)
  • [3] BL-M07D1, a novel HER2-targeting ADC, demonstrates potent anti-tumor efficacy in preclinical pharmacodynamic models
    Wan, Weili
    Zhao, Shuwen
    Zhuo, Shi
    Zhang, Yong
    Chen, Lan
    Li, Gangrui
    Khalili, Jahan Salar
    Xiao, Sa
    Yan, Yongqi
    Shen, Xuejiao
    Zhu, Yi
    CANCER RESEARCH, 2023, 83 (07)
  • [4] BL-M05D1, a novel claudin 18.2-targeting ADC, demonstrates specific potent antitumor efficacy in preclinical evaluation
    Wan, Weili
    Dinkel, Kelcey
    Sanford, Austin
    Zhao, Shuwen
    Zhuo, Shi
    Zhang, Yong
    Chen, Lan
    Li, Ruigang
    Khalili, Jahan Salar
    Sa, Xiao
    Yan, Yongqi
    Shen, Xuejiao
    Zhu, Yi
    CANCER RESEARCH, 2024, 84 (06)
  • [5] NN3201, a novel c- Kit targeting ADC, exhibits robust preclinical anti-tumor efficacy in SCLC and GIST models
    Kim, Chansik
    Cho, Jin Gu
    Wi, TaeMin
    Moon, Jiwoo
    Ko, Han-Jik
    Lee, Jina
    Park, Jin Woo
    Lee, Yeonjy
    Kim, Sanghee
    Kim, Jin-Ock
    Song, Jaeyoung
    Lee, Sun-Hwa
    Park, Sang Gyu
    CANCER RESEARCH, 2024, 84 (06)
  • [6] A monoclonal antibody targeting Trop-2 exhibits anti-tumor efficacy in human cancer models as a monotherapy and demonstrates efficacy in combination therapy
    Truong, A. H. L.
    Wang, M.
    Harris, V.
    Aziz, N.
    Grabell, J.
    Popp, L.
    Amoozgar, M.
    Hahn, S. E.
    Pereira, D. S.
    Young, D. S.
    EJC SUPPLEMENTS, 2008, 6 (12): : 165 - 165
  • [7] A novel EGFR x HER3-targeting bispecific antibody drug-conjugate, BCG019, demonstrates robust anti-tumor efficacy in preclinical evaluation
    Li, Zhuolin
    Shang, Chengzhang
    An, Gao
    Guo, Chaoshe
    An, W. Frank
    Yang, Yi
    CANCER RESEARCH, 2024, 84 (06)
  • [8] DB-1303, a HER2-targeting ADC with a novel DNA topoisomerase I inhibitor, demonstrates a promising safety profile and anti-tumor efficacy with differentiation from DS-8201a
    Lin, S.
    Zhang, Y.
    Li, B.
    Shi, R.
    Qiu, Y.
    Hua, H.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S91 - S91
  • [9] RGX-019-MMAE, a novel MERTK-targeting antibody-drug conjugate (ADC) with robust anti-tumor efficacy in both solid and liquid tumors.
    Takeda, Shugaku
    Lo, PuiChi
    Schefer, Daniel
    Andreu-Agullo, Celia
    Battula, Venkata Lokesh
    Maiti, Abhishek
    Tavazoie, Masoud
    Darst, David Martin
    Kurth, Isabel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] CCTx-001 CAR T-cells targeting the AML specific antigen IL-1RAP show robust preclinical anti-tumor efficacy
    De Dreuzy, Edouard
    El Sayed, Soha Reda
    Genin, Delphine
    Primus, Clementine
    Bouquet, Lucie
    Collette, Alexis
    Favre-Bulle, Olivier
    Rutjens, Erik
    Hasskarl, Jens
    Pavletic, Ksenija
    Deschamps, Marina
    Ferrand, Christophe
    Sainson, Richard C. A.
    CANCER RESEARCH, 2024, 84 (06)
123